These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 16771779

  • 21. Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis.
    Philip G, van Adelsberg J, Loeys T, Liu N, Wong P, Lai E, Dass SB, Reiss TF.
    J Allergy Clin Immunol; 2009 Nov; 124(5):942-8.e1-9. PubMed ID: 19748656
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Antihistamines added to an antileukotriene in treating seasonal allergic rhinitis: histamine and leukotriene antagonism.
    Ciprandi G, Tosca MA, Milanese M, Schenone G, Ricca V.
    Eur Ann Allergy Clin Immunol; 2004 Feb; 36(2):67-70, 72. PubMed ID: 15061398
    [Abstract] [Full Text] [Related]

  • 24. Efficacy comparison of levocetirizine vs montelukast in ragweed sensitized patients.
    Patel P, Patel D.
    Ann Allergy Asthma Immunol; 2008 Sep; 101(3):287-94. PubMed ID: 18814452
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
    Virchow JC, Bachert C.
    Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis.
    Yamamoto H, Yamada T, Sakashita M, Kubo S, Susuki D, Tokunaga T, Ogi K, Terasawa Y, Yamashita S, Kayano Y, Masada M, Kimura Y, Fujieda S.
    Allergy Asthma Proc; 2012 Nov; 33(2):e17-22. PubMed ID: 22525385
    [Abstract] [Full Text] [Related]

  • 28. A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis.
    Wilson AM, Orr LC, Coutie WJ, Sims EJ, Lipworth BJ.
    Clin Exp Allergy; 2002 Jan; 32(1):126-32. PubMed ID: 12002729
    [Abstract] [Full Text] [Related]

  • 29. Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat.
    Lieber G, Jimenez J, Hunter JC, McLeod RL, Jia Y.
    Pharmacology; 2010 Jan; 85(5):311-8. PubMed ID: 20453555
    [Abstract] [Full Text] [Related]

  • 30. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis.
    Mucha SM, deTineo M, Naclerio RM, Baroody FM.
    Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):164-72. PubMed ID: 16490874
    [Abstract] [Full Text] [Related]

  • 31. Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge.
    Georgitis JW, Meltzer EO, Kaliner M, Weiler J, Berkowitz R.
    Ann Allergy Asthma Immunol; 2000 Apr; 84(4):451-9. PubMed ID: 10795655
    [Abstract] [Full Text] [Related]

  • 32. Montelukast in general pediatric practices.
    Ngamphaiboon J.
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S348-51. PubMed ID: 16623053
    [Abstract] [Full Text] [Related]

  • 33. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis.
    Pullerits T, Praks L, Ristioja V, Lötvall J.
    J Allergy Clin Immunol; 2002 Jun; 109(6):949-55. PubMed ID: 12063523
    [Abstract] [Full Text] [Related]

  • 34. Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber.
    Zieglmayer P, Zieglmayer R, Bareille P, Rousell V, Salmon E, Horak F.
    Curr Med Res Opin; 2008 Jun; 24(6):1833-40. PubMed ID: 18498678
    [Abstract] [Full Text] [Related]

  • 35. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period.
    van Adelsberg J, Philip G, Pedinoff AJ, Meltzer EO, Ratner PH, Menten J, Reiss TF, Montelukast Fall Rhinitis Study Group.
    Allergy; 2003 Dec; 58(12):1268-76. PubMed ID: 14616102
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Nasal challenge with allergen leads to maxillary sinus inflammation.
    Baroody FM, Mucha SM, Detineo M, Naclerio RM.
    J Allergy Clin Immunol; 2008 May; 121(5):1126-1132.e7. PubMed ID: 18367240
    [Abstract] [Full Text] [Related]

  • 40. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.
    Akerlund A, Andersson M, Leflein J, Lildholdt T, Mygind N.
    J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.